Table 3. Comparison of mean IC50 titers of superinfected and singly infected study subjects against autologous pseudovirus variants.
Initial variants | Successive variants | ||||
Subject ID | Plasma sample | Mean IC50 | Fold increase | Mean IC50 | Fold increase |
Superinfected | |||||
CMNYU107 | First plasma | 10 | 4 | 10 | 4 |
Last plasma | 38* | 39* | |||
CMNYU6518 | First plasma | 12 | 9 | 12 | 7 |
Last plasma | 102* | 82* | |||
CMNYU129 | First plasma | 10 | 16 | 55 | 2 |
Last plasma | 156* | 89 | |||
CMNYU6544 | First plasma | 98 | 0 | 10 | 2 |
Last plasma | 75 | 20* | |||
Singly-infected | |||||
CMNYU133 | First plasma | 456 | 0 | 16 | 40 |
Last plasma | 252 | 633* | |||
CMNYU179 | First plasma | 12 | 4 | 16 | 4 |
Last plasma | 53* | 61* | |||
CMNYU153 | First plasma | 10 | 6 | 10 | 4 |
Last plasma | 56* | 38* | |||
CMNYU6542 | First plasma | 12 | 35 | 15 | 37 |
Last plasma | 419* | 548* |